IL10 and myelodysplastic syndrome: Studies have found that inhibitory factors, such as [34,35,36] IL-10 and IL-4, are significantly increased in high-risk groups, that IL-2 levels are also different, and IL-2 and IL-4 levels will help predict MDS prognosis in patients.